丙酸氟替卡松气雾剂或布地奈德混悬液干预对毛细支气管炎反复喘息的疗效观察  

Efficacy of fluticasone propionate aerosol versus budesonide suspension in treatment of recurrent wheezing caused by bronchiolitis

作　　者：兰伟平[1] 王婧[1] 代传林 潘家华[1] 

机构地区：[1]安徽医科大学附属省立医院儿科,安徽合肥230001

出　　处：《中国当代儿科杂志》2016年第4期316-319,共4页Chinese Journal of Contemporary Pediatrics

摘　　要：目的比较丙酸氟替卡松气雾剂(辅舒酮)和布地奈德混悬液对毛细支气管炎再发喘息的疗效观察。方法将初发毛细支气管炎患儿214例随机分为辅舒酮组(106例)和布地奈德组(108例),分别在临床症状缓解后继续给予辅舒酮或布地奈德规律吸入。另选取临床症状缓解后未规律吸入激素的毛细支气管炎患儿136例作为对照组。随访观察1年。评估2种干预治疗对患儿反复咳喘发作的影响。结果辅舒酮组和布地奈德组在1年内的咳喘次数以及前3个月的咳喘复发率均明显低于对照组(P<0.05),但两个治疗组之间差异无统计学意义(P>0.05)。布地奈德组在激素用量和治疗花费方面高于辅舒酮组(P<0.01)。结论毛细支气管炎患儿临床症状缓解后继续给予辅舒酮或布地奈德规律吸入可减少咳喘发作和复发。辅舒酮在治疗费用和激素用量方面优于布地奈德。Objective To investigate the efficacy of fluticasone propionate aerosol（flixotide） versus budesonide suspension in the treatment of recurrent wheezing caused by bronchiolitis. Methods A total of 214 infants with newly diagnosed bronchiolitis were randomly divided into flixotide treatment（106 infants） and budesonide treatment groups（108 infants）, and were given aerosol inhalation of flixotide or budesonide for 3 months after achieving remission of clinical symptoms. Another 136 infants with bronchiolitis who did not receive regular inhalation of corticosteroid after achieving remission of clinical symptoms were enrolled as the control group. The follow-up visits were performed for 1 year, and the effects of the two therapeutic methods on recurrent wheezing were evaluated. Results Compared with the control group, both the flixotide and budesonide treatment groups had significantly fewer times of wheezing episodes within 1 year and a significantly lower recurrence rate of wheezing within the first 3 months after regular inhalation of corticosteroid, but no significant differences were observed between the two treatment groups. The amount of corticosteroid inhaled and hospital costs in the budesonide treatment group were significantly higher than in the flixotide treatment group（P〈0.01）. Conclusions Continuous inhalation of flixotide or budesonide after remission of clinical symptoms in children with bronchiolitis can reduce wheezing episodes and the recurrence of wheezing, and flixotide treatment is superior to budesonide treatment in the aspects of hospital costs and the amount of corticosteroid used.

关 键 词：毛细支气管炎 吸入型糖皮质激素 反复喘息 儿童 

分 类 号：R725.6[医药卫生—儿科]